Jacqueline Elizabeth Shea
Chief Executive Officer, Director · INOVIO PHARMACEUTICALS, INC.
Individual
- 2025
- May 21, 2026
- 7
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jacqueline Elizabeth Shea's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
- AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jacqueline Elizabeth Shea?
Jacqueline Elizabeth Shea is a corporate insider, tracked as Chief Executive Officer, Director of INOVIO PHARMACEUTICALS, INC. (INO). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jacqueline Elizabeth Shea last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2026, one of 7 filings going back to 2025.
